PROVIDER PROFILE · NPI 1710113378
Mahsa TehraniM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
830
Unique beneficiaries
—
Total services
95,237
Distinct HCPCS
14
Medicare payment
$566K
Peer benchmark
Total Medicare services vs. 118 Rheumatology providers in VA — top quintile (cohort median 3,346).
PRESCRIBING · PART D · 2024
Total Rx claims
832
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
24
Brand share
33.9%
Top prescribed drugs
Hydroxychloroquine Sulfate167 claims
Prednisone123 claims
Methotrexate Sodium88 claims
Adalimumab52 claims
Celecoxib52 claims
QUALITY · MIPS · 2024
Final MIPS score
91.7
Quality
86.2
Cost
90.8
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.70%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
81
By payment type
Food and Beverage$2K
Education$165
Top paying entities
Food and Beverage$2K
Education$165
REFERRAL NETWORK
Where Mahsa Tehrani's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 43 | 353 |
| Quest Diagnostics Nichols Institute, Inc. Clinical Laboratory · Chantilly, VA | 21 | 70 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE